BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20009888)

  • 1. HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival.
    Li B; Jin H; Yu Y; Gu C; Zhou X; Zhao N; Feng Y
    Int J Gynecol Cancer; 2009 Nov; 19(8):1347-52. PubMed ID: 20009888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
    Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
    Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and drug resistance characteristics of ovarian clear cell adenocarcinoma and analysis of its prognostic factors].
    Zhang CY; Guo HY; Li H; Wen HW; Liang XD; Qiao J
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):688-91. PubMed ID: 23159083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP; Yu YH; Sheng C; Wang SH
    Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
    Barbolina MV; Adley BP; Shea LD; Stack MS
    Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis.
    Wan WN; Zhang YX; Wang XM; Liu YJ; Zhang YQ; Que YH; Zhao WJ
    Asian Pac J Cancer Prev; 2014; 15(6):2777-83. PubMed ID: 24761900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.
    Shinjo K; Yamashita Y; Yamamoto E; Akatsuka S; Uno N; Kamiya A; Niimi K; Sakaguchi Y; Nagasaka T; Takahashi T; Shibata K; Kajiyama H; Kikkawa F; Toyokuni S
    Int J Cancer; 2014 Jul; 135(2):308-18. PubMed ID: 24375438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
    Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
    Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.
    Xu Z; Tang H; Zhang T; Sun M; Han Q; Xu J; Wei M; Yu Z
    Life Sci; 2020 Jan; 241():117171. PubMed ID: 31843525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.
    Gu G; Chen Y; Duan C; Zhou L; Chen C; Chen J; Cheng J; Shi N; Jin Y; Xi Q; Zhong J
    Oncol Rep; 2017 Mar; 37(3):1511-1520. PubMed ID: 28098897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells.
    Chu MC; Selam FB; Taylor HS
    Cancer Biol Ther; 2004 Jun; 3(6):568-72. PubMed ID: 15044858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
    Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells.
    Giridhar PV; Funk HM; Gallo CA; Porollo A; Mercer CA; Plas DR; Drew AF
    Clin Exp Metastasis; 2011 Dec; 28(8):887-97. PubMed ID: 21887537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid sulfatase expression in ovarian clear cell adenocarcinoma: immunohistochemical study.
    Okuda T; Saito H; Sekizawa A; Shimizu Y; Akamatsu T; Kushima M; Yanaihara T; Okai T; Farina A
    Gynecol Oncol; 2001 Sep; 82(3):427-34. PubMed ID: 11520136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
    Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
    Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.